angiodynamics.com (ANGO): Operating Profitability

AngioDynamics Corp (ANGO) - corporate logo

AngioDynamics, Inc. (ANGO) is pivoting away from low-cost consumables to avoid pricing pressure. This margin-expansion strategy is linked to the implementation of NanoKnife AI systems for cancer treatment. Manufacturing capacities in the UK and US ensure the uninterrupted production of instruments. The operating profitability history clearly demonstrates profit dynamics, and -6.00 reflects the latest value of the metric.

ANGO - AngioDynamics Operating Profit Ratio over the range 07/04/2022 - 11/19/2026

Analytical breakdowns and data insights for company angiodynamics.com (ANGO)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:AngioDynamics Inc, ANGO
Finished products of AngioDynamics, Inc.

The operating margin of AngioDynamics, Inc. (ANGO) reflects the production efficiency of medical systems before accounting for financial expenses and taxes. This metric measures the share of profit from core operations relative to total sales, which is critical for assessing profitability. The current operating income as a percentage of revenue stands at -6.00. The trend of this indicator reveals the business's vulnerability to supply chain disruptions and sanction-related restrictions in target markets. Margin stability confirms the company's fundamental resilience to geopolitical shocks.

Competitors of AngioDynamics, Inc. (ANGO)

ISRG (intuitive.com) - Operating Margin|Return on Sales by Operating Profit DHR (Danaher Corp.)|Operating Sales Margin BDX (Becton, Dickinson and Company)|Operating Profit Ratio STE|Operating Profitability West Pharma WST|Profitability of Operations Baxter (BAX)|MASI - Operating Profitability|Profitability of Operations Stevanato Group Corp STVN|TFX: Operating Margin|Operating Sales Margin Merit Medical Systems|Operating Profitability Envista Holdings Corp|Operating Sales Margin ICU Medical Corp (ICUI)|Operating Profitability DENTSPLY SIRONA Inc. (XRAY)|Operating Sales Margin LeMaitre LMAT|Operating Margin ATRC (atricure.com)|Operating Margin staar.com STAA|NAGE - Operating Profitability|Profitability of Operations ZimVie ZIMV|CERS (Cerus Corp) - Operating Sales Margin|Alpha Teknova, Inc. - Operating Profit Rate|MGRM (Monogram Orthopedics Inc.) - Operating Margin|STSS: Operating Profit Rate|Operating Sales Margin INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Return on Sales by Operating Profit|Operating Margin KRMD (korumedical.com)|Profitability of Operations Nyxoah, S.A. (NYXH)|MBOT - Operating Profitability|PDEX (Pro-Dex, Inc.) - Return on Sales by Operating Profit|ZTEK (Zentek Ltd) - Operating Sales Margin|ELUT - Profitability of Operations|MLSS (Milestone Scientific Corporation) - Operating Margin|Return on Sales by Operating Profit NXGL (NEXGEL, Inc.)|Operating Margin RVP|Operating Sales Margin Harvard Bioscience HBIO|Operating Margin FEMY (Femasys Corporation)|MHUA - Operating Sales Margin|POAI - Operating Profitability|Callan JMB (CJMB) - Operating Sales Margin|ATRI: Operating Margin|NURO - Profitability of Operations